GW823296 Repeat Dose Study In Healthy Male And Female Subjects
NCT00675116
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Subjects
Interventions
DRUG:
GW823296
Sponsor
GlaxoSmithKline